Neutralization enzyme immunoassay for influenza virus
- PMID: 8027355
- PMCID: PMC267167
- DOI: 10.1128/jcm.32.4.987-990.1994
Neutralization enzyme immunoassay for influenza virus
Abstract
A neutralization enzyme immunoassay (N-EIA) was developed for the detection of antibody titer rises in sera of patients infected with influenza A (H3N2) virus. In this N-EIA, a selected strain of influenza A (H3N2) virus was added to monolayers of LLC-MK2 cells in microtiter plates. After 24 h, the replicated virus could be demonstrated with a virus-specific enzyme-labeled monoclonal antibody. Preincubation of the influenza virus with convalescent-phase sera of patients infected with influenza A (H3N2) virus resulted 1 day later in decreased absorbance values that could be used for calculation of neutralization titers. From use of paired serum samples from 10 patients with a history of flu-like symptoms, the results obtained with N-EIA correlated well (r = 0.83) with those of the standard hemagglutination inhibition test.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical